Annual Gross Profit
$29.39 M
-$10.49 M-26.30%
December 31, 2022
Summary
- As of March 10, 2025, SRNE annual gross profit is $29.39 million, with the most recent change of -$10.49 million (-26.30%) on December 31, 2022.
- During the last 3 years, SRNE annual gross profit has risen by +$10.19 million (+53.10%).
- SRNE annual gross profit is now -80.13% below its all-time high of $147.91 million, reached on December 31, 2017.
Performance
SRNE Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$6.57 M
-$4.49 M-40.61%
June 30, 2023
Summary
- As of March 10, 2025, SRNE quarterly gross profit is $6.57 million, with the most recent change of -$4.49 million (-40.61%) on June 30, 2023.
- Over the past year, SRNE quarterly gross profit has dropped by -$4.49 million (-40.61%).
- SRNE quarterly gross profit is now -94.56% below its all-time high of $120.83 million, reached on September 30, 2017.
Performance
SRNE Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$28.64 M
+$815.00 K+2.93%
June 30, 2023
Summary
- As of March 10, 2025, SRNE TTM gross profit is $28.64 million, with the most recent change of +$815.00 thousand (+2.93%) on June 30, 2023.
- Over the past year, SRNE TTM gross profit has increased by +$815.00 thousand (+2.93%).
- SRNE TTM gross profit is now -80.78% below its all-time high of $149.04 million, reached on March 31, 2018.
Performance
SRNE TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
SRNE Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.3% | -40.6% | +2.9% |
| 3 y3 years | +53.1% | -40.6% | +2.9% |
| 5 y5 years | -80.1% | -40.6% | +2.9% |
SRNE Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.3% | at low | -48.0% | +251.1% | -31.2% | +2.9% |
| 5 y | 5-year | -26.3% | +53.1% | -48.0% | +251.1% | -31.2% | +49.2% |
| alltime | all time | -80.1% | -100.0% | -94.6% | -100.0% | -80.8% | -100.0% |
Sorrento Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $6.57 M(-40.6%) | $28.64 M(+2.9%) |
| Mar 2023 | - | $11.06 M(+491.1%) | $27.83 M(-5.3%) |
| Dec 2022 | $29.39 M(-26.3%) | $1.87 M(-79.5%) | $29.39 M(-21.5%) |
| Sep 2022 | - | $9.13 M(+58.6%) | $37.45 M(+1.2%) |
| Jun 2022 | - | $5.76 M(-54.4%) | $37.00 M(-11.1%) |
| Mar 2022 | - | $12.63 M(+27.0%) | $41.63 M(+4.4%) |
| Dec 2021 | $39.87 M(+32.7%) | $9.94 M(+14.6%) | $39.87 M(+2.6%) |
| Sep 2021 | - | $8.68 M(-16.5%) | $38.86 M(-1.0%) |
| Jun 2021 | - | $10.39 M(-4.4%) | $39.27 M(+10.2%) |
| Mar 2021 | - | $10.87 M(+21.8%) | $35.63 M(+18.6%) |
| Dec 2020 | $30.05 M(+56.5%) | $8.92 M(-1.7%) | $30.05 M(-8.2%) |
| Sep 2020 | - | $9.08 M(+34.4%) | $32.73 M(+35.2%) |
| Jun 2020 | - | $6.76 M(+27.9%) | $24.20 M(+17.3%) |
| Mar 2020 | - | $5.28 M(-54.5%) | $20.64 M(+7.5%) |
| Dec 2019 | $19.20 M(+35.8%) | $11.61 M(+2003.6%) | $19.20 M(+57.8%) |
| Sep 2019 | - | $552.00 K(-82.7%) | $12.17 M(-10.2%) |
| Jun 2019 | - | $3.20 M(-16.7%) | $13.54 M(+3.9%) |
| Mar 2019 | - | $3.83 M(-16.3%) | $13.03 M(-7.8%) |
| Dec 2018 | $14.13 M(-90.4%) | $4.58 M(+137.8%) | $14.13 M(-51.2%) |
| Sep 2018 | - | $1.93 M(-28.2%) | $28.98 M(-80.4%) |
| Jun 2018 | - | $2.69 M(-45.6%) | $147.87 M(-0.8%) |
| Mar 2018 | - | $4.93 M(-74.6%) | $149.04 M(+0.8%) |
| Dec 2017 | $147.91 M(+1914.9%) | $19.43 M(-83.9%) | $147.91 M(+11.4%) |
| Sep 2017 | - | $120.83 M(+3039.1%) | $132.76 M(+864.6%) |
| Jun 2017 | - | $3.85 M(+1.0%) | $13.76 M(+30.8%) |
| Mar 2017 | - | $3.81 M(-11.0%) | $10.52 M(+43.3%) |
| Dec 2016 | $7.34 M | $4.28 M(+134.5%) | $7.34 M(+89.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $1.82 M(+200.7%) | $3.88 M(+52.0%) |
| Jun 2016 | - | $607.00 K(-3.5%) | $2.55 M(-9.0%) |
| Mar 2016 | - | $629.00 K(-22.7%) | $2.80 M(+6.1%) |
| Dec 2015 | $2.64 M(+48.1%) | $814.00 K(+63.1%) | $2.64 M(+21.0%) |
| Sep 2015 | - | $499.00 K(-41.9%) | $2.18 M(-10.3%) |
| Jun 2015 | - | $859.00 K(+83.5%) | $2.43 M(+32.3%) |
| Mar 2015 | - | $468.00 K(+31.8%) | $1.84 M(+3.1%) |
| Dec 2014 | $1.78 M(+290.8%) | $355.00 K(-52.6%) | $1.78 M(+16.9%) |
| Sep 2014 | - | $749.00 K(+182.6%) | $1.52 M(+77.6%) |
| Jun 2014 | - | $265.00 K(-35.8%) | $858.00 K(+16.7%) |
| Mar 2014 | - | $413.00 K(+325.8%) | $735.00 K(+61.2%) |
| Dec 2013 | $456.00 K(-21.9%) | $97.00 K(+16.9%) | $456.00 K(+27.0%) |
| Sep 2013 | - | $83.00 K(-41.5%) | $359.00 K(+30.1%) |
| Jun 2013 | - | $142.00 K(+6.0%) | $276.00 K(+106.0%) |
| Mar 2013 | - | $134.00 K(+46.0%) | $134.00 K(-85.3%) |
| Dec 2012 | $584.00 K(-14.4%) | - | - |
| Sep 2011 | - | $91.80 K(+23.7%) | $913.20 K(-2.4%) |
| Jun 2011 | - | $74.20 K(-68.5%) | $935.70 K(+1.9%) |
| Mar 2011 | - | $235.40 K(-54.0%) | $918.00 K(+34.5%) |
| Dec 2010 | $682.60 K(>+9900.0%) | $511.80 K(+347.8%) | $682.60 K(+299.6%) |
| Sep 2010 | - | $114.30 K(+102.3%) | $170.80 K(+202.3%) |
| Jun 2010 | - | $56.50 K(>+9900.0%) | $56.50 K(>+9900.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is Sorrento Therapeutics annual gross profit?
- What is the all time high annual gross profit for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual gross profit year-on-year change?
- What is Sorrento Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly gross profit year-on-year change?
- What is Sorrento Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Sorrento Therapeutics?
- What is Sorrento Therapeutics TTM gross profit year-on-year change?
What is Sorrento Therapeutics annual gross profit?
The current annual gross profit of SRNE is $29.39 M
What is the all time high annual gross profit for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual gross profit is $147.91 M
What is Sorrento Therapeutics annual gross profit year-on-year change?
Over the past year, SRNE annual gross profit has changed by -$10.49 M (-26.30%)
What is Sorrento Therapeutics quarterly gross profit?
The current quarterly gross profit of SRNE is $6.57 M
What is the all time high quarterly gross profit for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly gross profit is $120.83 M
What is Sorrento Therapeutics quarterly gross profit year-on-year change?
Over the past year, SRNE quarterly gross profit has changed by -$4.49 M (-40.61%)
What is Sorrento Therapeutics TTM gross profit?
The current TTM gross profit of SRNE is $28.64 M
What is the all time high TTM gross profit for Sorrento Therapeutics?
Sorrento Therapeutics all-time high TTM gross profit is $149.04 M
What is Sorrento Therapeutics TTM gross profit year-on-year change?
Over the past year, SRNE TTM gross profit has changed by +$815.00 K (+2.93%)